- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Indian Medicines Pharmaceutical Corp pays Rs 10 crore dividend to stakeholders
New Delhi: Indian Medicines Pharmaceutical Corporation (IMPCL), a central public sector enterprise (CPSE), under the Ministry of Ayush, Government of India, has announced to pay a dividend of Rs 10.13 Crores to its stakeholders - Ministry of Ayush and Government of Uttarakhand. The dividend cheque of Rs 9.93 Crores for the Ministry of Ayush was handed over to the Union Minister of Ayush Shri Sarbananda Sonowal in a ceremony held at Transport Bhawan.
On this occasion, Shri Sarbananda Sonowal said, "IMPCL Ltd. has registered an impressive increase in its profits in comparison to the last Financial Year 2020-21, which is a commendable achievement. Under the visionary leadership of Prime Minister Shri Narendra Modi, the Ayush sector is witnessing all-round growth not only in India but globally."
The dividend cheque handover ceremony was attended by MoS for Ayush Shri Majapara Mahendrabhai; Special Secretary, Ministry of Ayush Shri Pramod Kumar Pathak; Director Yoga and Naturopathy cell, Ministry of Ayush Shri Vikram Singh; Advisor Ayurveda, Dr. Mukesh Kumar MD, IMPCL Ltd.; Shri Arvind Kumar Aggarwal, AGM (F&A), IMPCL Ltd. and others.
Dr. Mukesh Kumar, MD, IMPCL Ltd said, "In the operational front the company has achieved an enhancement of 47% in capacity utilization over its previous year. An all-around enhancement in performance in terms of turnover, profit, and capacity utilization over previous years has brought focus on the future prospects of the company."
IMPCL Ltd. has been conferred Mini Ratna Category II status by the Government of India and also got ISO 9001:2015 Certification. The Company is presently manufacturing 656 Classical Avurvedic, 332 Unani, and 71 Proprietary Avurvedic Medicines for the various diseases spectrum. It supplies Ayurveda and Unani medicines to all the States under the National Ayush Mission (NAM) and 6000 centres of Jan Aushadhi Kendras.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751